Robert Nelsen - Dec 20, 2021 Form 4/A - Amendment Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director, 10%+ Owner
Signature
By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Dec 20, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/10/2022, 05:26 PM
Date Of Original Report
Dec 22, 2021
Previous filing
Dec 1, 2021
Next filing
Apr 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 +102K +70.13% $0.00 248K Dec 20, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
F3 Correction made to include shares previously reported in prior filing on 5/21/21 but not included in the amount of shares beneficially owned in subsequent filings.